MIGS comanagement ‘next horizon’ for optometry
Dr. Donnenfeld named one of the top ophthalmologists by Becker’s ASC Review
ASCRS Annual Update 2014
Dr. Eric Donnenfeld, President of ASCRS, provides an update on the Society’s activities. Revised draft for approval. Produced by AVMG/Freeman for ASCRS.
Intense Pulsed Light Treatment for Rosacea and Dry Eyes
- Changing the NSAID Paradigm
- IOL’s for Cataract Refractive Surgery
- Keratoconus and Corneal Ectasia After LASIK
- ReSTOR – Physician to OD Presentation
- Aspheric IOL Design and Clinical Implications
- Incorporating Cyclosporine Ophthalmic into Your Treatment Regimen
- Iris-Fixated Phakic IOLs
- Clinical Results with Customized Ablation Technology
- Therapeutic Updates
- Preparing the Ocular Surface for Refractive Surgery
- Transitioning from Cataract to Refractive IOL Surgery?
Note: These files are in PDF format. If you do not have Adobe® Reader® on your computer, you can download it for free by clicking here or on the Get Adobe Reader icon.
LenSX Laser for Laser Cataract Surgery at Ophthalmic Consultants of Connecticut
Ophthalmic Consultants of Connecticut is proud to offer laser cataract surgery with LenSX laser technology. The use of LenSX represents a revolutionary approach to yielding even safer and more accurate cataract surgery results. After being successfully used in bladeless LASIK surgery, the femtosecond laser has now become a brand new method of creating surgical incisions in the eye while ensuring unsurpassed precision.
The revolutionary LenSX laser platform offers our cataract surgery patients a range of benefits. At OCC, we use this technology to provide customizable treatments with image-guided visualization and unsurpassed micro-level precision.
Laser cataract surgery with LenSX allows us to:
- Create perfect incisions in terms of size and thickness. This allows for proper healing and eliminates any complications associated with stitches and other sealing methods.
- Create perfectly centered and sized capsulotomy (the opening in front of the crystalline lens through which the lens is removed.)
- Liquefy the crystalline lens for easy removal
- Create precise limbal relaxing incisions, which are performed during cataract surgery to treat astigmatism.
Clinical studies of the LenSx laser, including one conducted at the prestigious Bascom Palmer Eye Institute, show that laser cataract surgery is even safer and less error-prone than the advanced no-stitch cataract surgery. In fact, patients who received laser cataract surgery compared to those who underwent the manual cataract procedure experienced a shorter recovery and greater visual results. In addition, laser cataract surgery preserves the endothelial cells, which preserve clarity of the cornea.
New Orleans Bestows special honor on Dr. Eric Donnenfeld of TLC Vision Centers
April 30, Fairfield, CT – Eric Donnenfeld, M.D., an ophthalmologist with TLC Vision Centers of Connecticut, was recently honored by Mayor C. Ray Nagin of the City of New Orleans.
TLC Vision Centers | FairfieldMayor Nagin proclaimed March 11, 2006 as a Special Day of Honor for Dr. Donnenfeld. This honor was bestowed at the 55th Annual Symposium of the New Orleans Academy of Ophthalmology for outstanding humanitarian services which Dr. Donnenfeld provided to the City of New Orleans in the aftermath of Hurricanes Katrina and Rita.
Dr. Donnenfeld has performed over 35,000 laser vision correction procedures and is the Co-Director of the Cornea Department at Nassau University Medical Center, East Meadow, New York, and Co-Director of the External Disease / Cornea Department at Manhattan Eye, Ear and Throat Hospital, New York, New York. He is the Surgical Director of the Lions Eye Bank for Long Island at the North Shore University Hospital and is an Assistant Clinical Professor of Ophthalmology at New York University Medical College.
Dr. Donnenfeld has been one of the principal investigators of the Excimer Laser Study for Corneal Disease at Manhattan Eye, Ear and Throat Hospital. In addition, he has written over 140 scientific papers and books on corneal disease and refractive surgery. Dr. Donnenfeld has delivered lectures throughout the United States and abroad on refractive surgery and is considered an international authority on the subject.
VISX Iris Registration Product Approved by the FDA
VISX Iris Registration Product Approved by the FDA; Adds Individualized Precision to Laser Vision Correction
SANTA CLARA, Calif.–(BUSINESS WIRE)–March 2, 2005–VISX, INCORPORATED (NYSE: EYE) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market and sell Iris Registration technology, the first fully automated method of aligning and registering wavefront corrections for CustomVue treatment. Iris Registration is designed to replace the current means of registration, which involves manual marking of the eye to assess rotational movement.
Refractive Surgery FairfieldJulian Stevens, M.D., of Moorfields Eye Hospital, London, England, stated, “Iris Registration adds another level of sophistication to wavefront guided laser vision correction. By automatically adjusting the treatment for the eye’s rotation, Iris Registration provides more individualized adjustments that improve the precision of laser vision correction. This further enhances the quality of vision we achieve with the procedure.”
Liz Davila, VISX Chairman and CEO, stated, “We are committed to providing products that advance the capabilities of CustomVue laser vision correction. We are first to market with a fully automated Iris Registration product, which follows two other groundbreaking products introduced at the end of last year, our Fourier Software and CustomVue Hyperopia.”
Davila continued, “As shown in FDA clinical studies, CustomVue has the potential to offer vision better than what can be achieved with glasses and contacts. Our continued advancements make the CustomVue procedure more precise and personalized.”
Iris Registration is a hardware and software product enhancement that is a field installed upgrade to the VISX WaveScan and VISX STAR laser systems. VISX intends to begin U.S. shipment of Iris Registration in the second quarter.